QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Résumé Extracto Full Text PDF Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Articles Ahead of Print [Order Reprint] Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bergeron, L. Articles by Perreault, S. Search for Related Content PubMed PubMed Citation Articles by Bergeron, L. Articles by Perreault, S.

Serotonin Toxicity Associated with Concomitant Use of Linezolid

Clinical Pharmacist, Department of Pharmacy, Centre Hospitalier de Québec; Associate Clinical Professor, Faculty of Pharmacy, Laval University, Quebec, Canada

Martin Boulé, MSc

Clinical Pharmacist, Department of Pharmacy, Centre Hospitalier de Québec; Associate Clinical Professor, Faculty of Pharmacy, Laval University

Sébastien Perreault, MSc

Clinical Pharmacist, Department of Pharmacy, Centre Hospitalier de Québec; Associate Clinical Professor, Faculty of Pharmacy, Laval University

Reprints: Mr. Bergeron, Départment de pharmacie, CHUL du CHUQ, 2705, boul. Laurier, Rm. RC-206, Sainte-Foy QC G1V 4G2, Canada, fax 418/654-2154, luc.bergeron{at}chuq.qc.ca

OBJECTIVE: To report 2 cases of serotonin toxicity (ST) associated with concomitant use of linezolid and serotonergic drugs and review previously published case reports.

CASE SUMMARIES: Case 1. A 38-year-old white female with cystic fibrosis treated with venlafaxine 300 mg/day for one year was prescribed linezolid 600 mg intravenously every 12 hours for treatment of methicillin-resistant Staphylococcus aureus (MRSA) pulmonary infection. She displayed symptoms of ST 8 days after the introduction of linezolid. The venlafaxine dosage was decreased to 150 mg/day, and symptoms gradually abated over 36 hours. Case 2. A 37-year-old male with multiple myeloma received citalopram 40 mg/day and trazodone 150 mg/day for anxiety-related disorders. Linezolid treatment with 600 mg orally twice daily was instituted for MRSA cellulitis. The following day, the patient developed anxiety, panic attacks, tremors, tachycardia, and hypertension that persisted throughout linezolid treatment. Symptoms finally waned 5 days after linezolid treatment was stopped.

DISCUSSION: The symptoms observed in our patients were consistent with Sternbach's criteria for ST. A review of published case reports showed a short time to onset of symptoms following the introduction of linezolid, generally within 1–3 days. Also of note is the use of relatively high dosages of serotonergic drugs. Use of the Naranjo probability scale indicated a possible relationship between the use of linezolid and the occurrence of ST in both cases.

CONCLUSIONS: Clinicians should pay special attention to patients treated with serotonergic drugs, especially those receiving dosages in the higher end of the normal range who are prescribed linezolid, and consider tapering or reducing the dosage of serotonergic drugs for the duration of antibiotic therapy.

Key Words: citalopram, linezolid, serotonin syndrome, venlafaxine

Published Online, April 12, 2005. www.theannals.com, DOI 10.1345/aph.1E523

This article has been cited by other articles:

				T. Z Jodlowski, I. Melnychuk, and J. Conry Linezolid for the Treatment of Nocardia spp. Infections Ann. Pharmacother., October 1, 2007; 41(10): 1694 - 1699. [Abstract] [Full Text] [PDF]

				S. PACKER and S. A. BERMAN Serotonin Syndrome Precipitated by the Monoamine Oxidase Inhibitor Linezolid Am J Psychiatry, February 1, 2007; 164(2): 346 - 347. [Full Text] [PDF]

				J. A. Morales-Molina, J. M.-d. Antonio, M. Marin-Casino, and S. Grau Linezolid-associated serotonin syndrome: what we can learn from cases reported so far J. Antimicrob. Chemother., December 1, 2005; 56(6): 1176 - 1178. [Abstract] [Full Text] [PDF]